Michael Stevens
Nessuna posizione attualmente
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Richard R. Whipp | M | 70 | 13 anni | |
| Jost Fischer | M | 69 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 7 anni |
| Ed Inal | M | - |
Strathspey Crown LLC
 Strathspey Crown LLC Investment ManagersFinance Strathspey Crown LLC (Strathspey Crown) is a private equity firm founded in 2012 by Robert Grant. The firm is headquartered in Newport Beach, California. | 3 anni |
| Jared Klumker | M | - |
Strathspey Crown LLC
Strathspey Crown LLC Investment ManagersFinance Strathspey Crown LLC (Strathspey Crown) is a private equity firm founded in 2012 by Robert Grant. The firm is headquartered in Newport Beach, California. | 6 anni |
| Stephen l Jang | M | - | 12 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Mulder | M | 63 | 2 anni | |
| Alexander Arrow | M | 53 | 4 anni | |
| Jeffrey W. Jones | M | 62 | 9 anni | |
| Robert Grant | M | 55 | 3 anni | |
| Jeffrey M. Nugent | M | 76 | 1 anni | |
| Murthy Simhambhatla | M | 58 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 anni |
| Paul Clark | M | 76 | 3 anni | |
| Frederick D. Furry | M | 54 | 5 anni | |
| Frederick M. Capallo | M | 64 | 3 anni | |
| Marilyn A. Lobel | F | 70 | 1 anni | |
| Norman J. Nemoy | M | 84 | 4 anni | |
| James R. Talevich | M | 73 | 5 anni | |
| Gregory E. Lichtwardt | M | 69 | 3 anni | |
| Ehab M. Esmail | M | - | - | |
| George V. D'Arbeloff | M | 79 | 14 anni | |
| Frederic Moll | M | 72 | 4 anni | |
| Samuel B. Low | M | - | 1 anni | |
| Brendan O'Connell | M | 47 | 12 anni | |
| Bosun Hau | M | 45 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | - |
| Barton Bandy | M | 63 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 anni |
| Orlando P. Rodrigues | M | 62 | - | |
| Colleen M. Boswell | F | - | - | |
| Peter Rowland | M | - | 6 anni | |
| Jake P. St. Philip | M | 71 | 1 anni | |
| Neil Laird | M | 70 | 4 anni | |
| Brett Scott | M | 73 | 1 anni | |
| Christopher Cox | M | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 anni |
| James R. Largent | M | 74 | 3 anni | |
| Daniel S. Durrie | M | 73 | 4 anni | |
| John W. Hohener | M | 69 | 2 anni | |
| Richard L. Harrison | M | 67 | 3 anni | |
| Keith G. Bateman | M | 71 | 8 anni | |
| Gregory Waller | M | 74 | 1 anni | |
| Dennis Wolf | M | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 anni |
| Craig S. Kussman | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 anni |
| Brian D. Jaffe | M | 63 | - | |
| Erin Enright | F | 63 | - | |
| Robert M. Anderton | M | 87 | 6 anni | |
| Ryan Meardon | M | 44 | 9 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 44 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michael Stevens
- Contatti personali
